UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 202

Sortiert nach

Recent advances in clinical practice: epidemiology of autoimmune liver diseases

Gut, 2021-10, Vol.70 (10), p.1989

2021

Volltextzugriff (PDF)

Editorial: liver disease in secondary care—‘money or your life’

Alimentary pharmacology & therapeutics, 2021-09, Vol.54 (6), p.854-855

Trivedi, Palak. J.

2021

Volltextzugriff (PDF)

Risk stratification in primary sclerosing cholangitis: It’s time to move on from replicating imperfection and break the glass ceiling

Journal of hepatology, 2019-11, Vol.71 (5), p.867-870

Trivedi, Palak J.

2019

Volltextzugriff (PDF)

Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?

Digestive diseases and sciences, 2024-04, Vol.69 (4), p.1083-1087

2024

Volltextzugriff (PDF)

Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise

Journal of Crohn's and colitis, 2018-08, Vol.12 (suppl_2), p.S641-S652

2018

Volltextzugriff (PDF)

Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age

Gastroenterology (New York, N.Y. 1943), 2020-09, Vol.159 (3), p.915-928

2020

Volltextzugriff (PDF)

Gut – Liver Immunity

Journal of hepatology, 2016-05, Vol.64 (5), p.1187-1189

2016

Volltextzugriff (PDF)

The Inconvenient Truth of Primary Biliary Cholangitis/Autoimmune Hepatitis Overlap Syndrome

Clinics in liver disease, 2022-11, Vol.26 (4), p.657-680

2022

Volltextzugriff (PDF)

Primary sclerosing cholangitis and the risks of posttransplant lymphoproliferative disorder

Liver transplantation, 2024-06, Vol.30 (6), p.567-569

2024

Volltextzugriff (PDF)

Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?

Journal of hepatology, 2023-08, Vol.79 (2), p.567-575

2023

Volltextzugriff (PDF)

Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis

Clinical gastroenterology and hepatology, 2019-12, Vol.17 (13), p.2785-2792.e3

2019

Volltextzugriff (PDF)

Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists

Hepatology (Baltimore, Md.), 2016-02, Vol.63 (2), p.644-659

2016

Volltextzugriff (PDF)

Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies

Clinical gastroenterology and hepatology, 2022-08, Vol.20 (8), p.1687-1700.e4

2022

Volltextzugriff (PDF)

Mucosal immunity in liver autoimmunity: A comprehensive review

Journal of autoimmunity, 2013-10, Vol.46, p.97-111

2013

Volltextzugriff (PDF)

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

Gastroenterology (New York, N.Y. 1943), 2015-12, Vol.149 (7), p.1804-1812.e4

2015

Volltextzugriff (PDF)

Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts

Gastroenterology (New York, N.Y. 1943), 2024-06, Vol.166 (6), p.995-1019

2024

Volltextzugriff (PDF)

Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise

Journal of Crohn's and colitis, 2018-11, Vol.12 (12), p.1508-1508

2018

Volltextzugriff (PDF)

Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC)

Baillière's best practice & research. Clinical gastroenterology, 2018-06, Vol.34-35, p.71-83

2018

Volltextzugriff (PDF)

Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again

Current opinion in gastroenterology, 2022-03, Vol.38 (2), p.104

2022

Volltextzugriff (PDF)

Grand round: Autoimmune hepatitis

Journal of hepatology, 2019-04, Vol.70 (4), p.773-784

2019

Volltextzugriff (PDF)

Role of microbiome in autoimmune liver diseases

Hepatology (Baltimore, Md.), 2023-06

2023

Volltextzugriff (PDF)

Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

Gastroenterology (New York, N.Y. 1943), 2014-12, Vol.147 (6), p.1338-1349.e5

2014

Volltextzugriff (PDF)

1 – 25 von 202

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(92)
Gastroenterology & Hepatology
(75)
Humans
(71)
Male
(29)
Female
(27)
Middle Aged
(25)
Cholangitis
(24)
Adult
(23)
Liver
(20)
Liver Transplantation
(19)
Hepatology
(18)
Autoimmune Liver Disease
(17)
Ursodeoxycholic Acid - Therapeutic Use
(17)
Gastroenterology And Hepatology
(16)
Liver Cirrhosis, Biliary - Drug Therapy
(16)
Cholestasis
(14)
Liver Diseases
(14)
Primary Sclerosing Cholangitis
(14)
Inflammatory Bowel Disease
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(21)

Menü

Weitere Dienste

Einstellungen

Recent advances in clinical practice: epidemiology of autoimmune liver diseases

Editorial: liver disease in secondary care—‘money or your life’

Risk stratification in primary sclerosing cholangitis: It’s time to move on from replicating imperfection and break the glass ceiling

Risk Stratification in Primary Sclerosing Cholangitis: Does Size Matter?

Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise

Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age

Gut – Liver Immunity

The Inconvenient Truth of Primary Biliary Cholangitis/Autoimmune Hepatitis Overlap Syndrome

Primary sclerosing cholangitis and the risks of posttransplant lymphoproliferative disorder

Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?

Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis

Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists

Epidemiology, Natural History, and Outcomes of Primary Sclerosing Cholangitis: A Systematic Review of Population-based Studies

Mucosal immunity in liver autoimmunity: A comprehensive review

Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study

Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts

Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise

Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC)

Mucosal immunity in primary sclerosing cholangitis: from the bowel to bile ducts and back again

Grand round: Autoimmune hepatitis

Role of microbiome in autoimmune liver diseases

Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner

Suchergebnisse filtern